SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-098703
Filing Date
2020-08-26
Accepted
2020-08-26 16:36:15
Documents
3
Period of Report
2020-08-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2029422-1_8k.htm 8-K 21045
2 EXHIBIT 99.1 tm2029422d1_ex99-1.htm EX-99.1 660652
3 GRAPHIC tm2029422d1_ex99-1img01.jpg GRAPHIC 7637
  Complete submission text file 0001104659-20-098703.txt   693695
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 201137656
SIC: 2834 Pharmaceutical Preparations